Brief report: killer cell defect and persistent immunological abnormalities in two patients with chronic active Epstein-Barr virus infection
- PMID: 2544675
- DOI: 10.1002/jmv.1890280211
Brief report: killer cell defect and persistent immunological abnormalities in two patients with chronic active Epstein-Barr virus infection
Abstract
Two members of a family have manifested a syndrome of chronic active Epstein-Barr virus (EBV) infection. A father and his daughter suffered prolonged or recurrent mononucleosis, with splenomegaly, anemia, and intermittent fever; persistent immunological abnormalities included defective natural killer (NK) cytotoxicity, inverted CD4/CD8 ratios, hyper IgG1, high EBV viral capsid antigen (VCA) and early antigen (EA) antibodies, and low or undetectable EBV nuclear antigen (EBNA) antibody titers. The EBV seronegative member of the family was free of these abnormalities. However, NK activity in the seronegative individual was low-normal and its EBV-specific antibody-dependent K-cell cytotoxicity (EBV-ADCC) was abnormally low, suggesting that this K-NK cell defect may be primary. The father, who suffered from the syndrome for more than 15 years, lacked (or lost) antibodies to EBV-envelope and infected cell membranes, such as antibody-dependent cellular cytotoxicity (ADCC), neutralizing (NT), and gp 350/220 antibodies. Slow improvement over a period of years was heralded by rising NK cytotoxicity.
Similar articles
-
Elevated antibody titers to Epstein-Barr virus and low natural killer cell activity in patients with Chediak-Higashi syndrome.Clin Immunol Immunopathol. 1983 Jun;27(3):326-39. doi: 10.1016/0090-1229(83)90085-5. Clin Immunol Immunopathol. 1983. PMID: 6307571
-
Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.J Clin Virol. 2007 Apr;38(4):292-7. doi: 10.1016/j.jcv.2007.01.006. Epub 2007 Mar 1. J Clin Virol. 2007. PMID: 17336144
-
Subclass reactivity to Epstein-Barr virus capsid antigen in primary and reactivated EBV infections.J Med Virol. 1987 Feb;21(2):109-21. doi: 10.1002/jmv.1890210203. J Med Virol. 1987. PMID: 3029317
-
Epstein-Barr virus (EBV)-specific cell-mediated and humoral immune responses in ataxia-telangectasia patients.J Clin Immunol. 1984 Sep;4(5):369-82. doi: 10.1007/BF00917140. J Clin Immunol. 1984. PMID: 6092413 Review.
-
Chronic mononucleosis: pitfalls in the laboratory diagnosis.Hum Pathol. 1986 Jan;17(1):2-8. doi: 10.1016/s0046-8177(86)80149-6. Hum Pathol. 1986. PMID: 3002949 Review. No abstract available.
Cited by
-
Genetically associated CD16(+)56(-) natural killer cell interferon (IFN)-αR expression regulates signaling and is implicated in IFN-α-induced hepatitis C virus decline.J Infect Dis. 2012 Apr 1;205(7):1131-41. doi: 10.1093/infdis/jis027. Epub 2012 Feb 20. J Infect Dis. 2012. PMID: 22351942 Free PMC article.
-
Development and functions of natural killer cells.Int J Hematol. 2003 Jul;78(1):1-6. doi: 10.1007/BF02983233. Int J Hematol. 2003. PMID: 12894844 Review.
-
Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States.Blood. 2011 Jun 2;117(22):5835-49. doi: 10.1182/blood-2010-11-316745. Epub 2011 Mar 31. Blood. 2011. PMID: 21454450 Free PMC article.
-
Epstein-Barr virus infection and associated diseases in children. I. Pathogenesis, epidemiology and clinical aspects.Eur J Pediatr. 1992 Oct;151(10):718-25. doi: 10.1007/BF01959075. Eur J Pediatr. 1992. PMID: 1330572 Review.
-
Case report: Systemic muscle involvement as the primary clinical manifestation of chronic active Epstein-Barr virus infection: A case-based review.Front Immunol. 2022 Oct 7;13:1027859. doi: 10.3389/fimmu.2022.1027859. eCollection 2022. Front Immunol. 2022. PMID: 36275709 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials